Cationic liposomes as adjuvants for influenza hemagglutinin: More than charge alone

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 2, 2012, Pages 294-302

  Barnier Quer, Christophe ^a   Elsharkawy, Abdelrahman ^a   Romeijn, Stefan ^a   Kros, Alexander ^b   Jiskoot, Wim ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adjuvant; Antigen; Cationic liposome; Hemagglutinin; Influenza vaccine; Subunit vaccine

Indexed keywords

1,2 DIACYL SN GLYCERO 3 ETHYLPHOSPHOCHOLINE; 1,2 DIPALMITOYL 3 TRIMETHYLAMMONIUM PROPANE; 3 BETA [N (N',N' DIMETHYLAMINOETHANE) CARBAMOYL]CHOLESTEROL; ADJUVANT; CATION; DIOCTADECYL AMMONIUM BROMIDE; HEMAGGLUTININ; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INFLUENZA HEMAGGLUTININ; LIPID; LIPOSOME; NEUTRALIZING ANTIBODY; PHOSPHOLIPID; PROPANE; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION; HYDRATION; HYDRODYNAMICS; IMMUNOGENICITY; MEMBRANE FLUIDITY; MOUSE; NONHUMAN; PHASE TRANSITION; PHYSICAL CHEMISTRY; SERUM; ZETA POTENTIAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CATIONS; CHEMISTRY, PHARMACEUTICAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS; INFLUENZA VACCINES; LIPIDS; LIPOSOMES; MEMBRANE FLUIDITY; MICE; MICE, INBRED C57BL; PARTICLE SIZE; PHASE TRANSITION; PHOSPHOLIPIDS;

EID: 84861601604     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.03.013     Document Type: Article

References (41)

1. P.R. Dormitzer, G. Galli, F. Castellino, H. Golding, S. Khurana, G. Del Giudice, and R. Rappuoli Influenza vaccine immunology Immunol. Rev. 239 2011 167 177
2. R.A. Tripp, and S.M. Tompkins Recombinant vaccines for influenza virus Curr. Opin. Invest. Drugs 9 2008 836 845
3. F. Krammer, and R. Grabherr Alternative influenza vaccines made by insect cells Trends Mol. Med. 16 2010 313 320
4. S. Esposito, A. Selicorni, C. Daleno, A. Valzano, M. Cerutti, C. Galeone, S. Consolo, F. Menni, N. Principi, Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome, Hum. Vaccin 7 (2011).
5. J.H. Wilson-Welder Vaccine adjuvants: current challenges and future approaches J. Pharm. Sci. 98 2009 1278 1316
6. D.T. O'Hagan, and R. Rappuoli Novel approaches to vaccine delivery Pharm. Res. 21 2004 1519 1530
7. G.F. Kersten, and D.J. Crommelin Liposomes and ISCOMs Vaccine 21 2003 915 920
8. G. Gregoriadis, A. Bacon, W. Caparros-Wanderley, and B. McCormack A role for liposomes in genetic vaccination Vaccine 20 Suppl. 5 2002 B1 B9
9. D. Christensen, K.S. Korsholm, P. Andersen, and E.M. Agger Cationic liposomes as vaccine adjuvants Expert. Rev. Vaccines 10 2011 513 521
10. F. Nimmerjahn, and J. Ravetch Fc gamma receptors: old friends and new family members Immunity 24 2006 19 28
11. M. Henriksen-Lacey, V.W. Bramwell, D. Christensen, E.M. Agger, P. Andersen, and Y. Perrie Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen J. Control. Release 142 2010 180 186
12. M. Brgles, L. Habjanec, B. Halassy, and J. Tomasic Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response Vaccine 27 2009 5435 5442
13. W. Chen, W. Yan, and L. Huang A simple but effective cancer vaccine consisting of an antigen and a cationic lipid Cancer Immunol. Immunother. 57 2008 517 530
14. X. Jiao, R.Y. Wang, Z. Feng, H.J. Alter, and J.W. Shih Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization Hepatology 37 2003 452 460
15. D. Christensen, C. Foged, I. Rosenkrands, H.M. Nielsen, P. Andersen, and E.M. Agger Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying Biochim. Biophys. Acta 1768 2007 2120 2129
16. B. Guy, N. Pascal, A. Francon, A. Bonnin, S. Gimenez, E. Lafay-Vialon, E. Trannoy, and J. Haensler Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine Vaccine 19 2001 1794 1805
17. I. Rosenkrands, E.M. Agger, A.W. Olsen, K.S. Korsholm, C.S. Andersen, K.T. Jensen, and P. Andersen Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system Infect. Immun. 73 2005 5817 5826
18. A. Joseph, N. Itskovitz-Cooper, S. Samira, O. Flasterstein, H. Eliyahu, D. Simberg, I. Goldwaser, Y. Barenholz, and E. Kedar A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice Vaccine 24 2006 3990 4006
19. S.E. McNeil, I. Rosenkrands, E.M. Agger, P. Andersen, and Y. Perrie Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system J. Pharm. Sci. 100 2011 1856 1865
20. J.R. Silvius, and R.N. McElhaney Molecular properties of membrane lipids and activity of a membrane adenosine triphosphatase from Acholeplasma laidlawii B Rev. Infect. Dis. 4 Suppl. 1982 S50 S58
21. E. Feitosa, F.R. Alves, A. Niemiec, M.E. Real Oliveira, E.M. Castanheira, and A.L. Baptista Cationic liposomes in mixed didodecyldimethylammonium bromide and dioctadecyldimethylammonium bromide aqueous dispersions studied by differential scanning calorimetry, Nile Red fluorescence, and turbidity Langmuir 22 2006 3579 3585
22. R. Koynova, and R.C. MacDonald Cationic O-ethylphosphatidylcholines and their lipoplexes: phase behavior aspects, structural organization and morphology Biochim. Biophys. Acta 1613 2003 39 48
23. M.O. Oyewumi, A. Kumar, and Z. Cui Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses Expert Rev. Vaccines 9 2010 1095 1107
24. M. Singh, A. Chakrapani, and D. O'Hagan Nanoparticles and microparticles as vaccine-delivery systems Expert Rev. Vaccines 6 2007 797 808
25. M. Henriksen-Lacey, A. Devitt, and Y. Perrie The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production J. Control. Release 154 2011 131 137
26. C. Barnier Quer, H. Robson Marsden, S. Romeijn, H. Zope, A. Kros, and W. Jiskoot Polymersomes enhance the immunogenicity of influenza subunit vaccine Polym. Chem. 2 2011 1482 1485
27. J.P. Amorij, V. Saluja, A.H. Petersen, W.L. Hinrichs, A. Huckriede, and H.W. Frijlink Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice Vaccine 25 2007 8707 8717
28. B. Slütter, L. Plapied, V. Fievez, M.A. Sande, A. des Rieux, Y.J. Schneider, E. Van Riet, W. Jiskoot, and V. Preat Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosalvaccination J. Control. Release 138 2009 113 121
29. Y. Ma, Y. Zhuang, X. Xie, C. Wang, F. Wang, D. Zhou, J. Zeng, and L. Cai The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses Nanoscale 3 2011 2307 2314
30. M. Henriksen-Lacey, D. Christensen, V.W. Bramwell, T. Lindenstrom, E.M. Agger, P. Andersen, and Y. Perrie Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3beta-[N-(N′,N′-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses Mol. Pharm. 8 2011 153 161
31. J. Davidsen, I. Rosenkrands, D. Christensen, A. Vangala, D. Kirby, Y. Perrie, E.M. Agger, and P. Andersen Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate) - a novel adjuvant inducing both strong CMI and antibody responses Biochim. Biophys. Acta 1718 2005 22 31
32. C. Demetzos Differential Scanning Calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability J. Liposome Res. 18 2008 159 173
33. D.A. Mannock, M.Y. Lee, R.N. Lewis, and R.N. McElhaney Comparative calorimetric and spectroscopic studies of the effects of cholesterol and epicholesterol on the thermotropic phase behaviour of dipalmitoylphosphatidylcholine bilayer membranes Biochim. Biophys. Acta 1778 2008 2191 2202
34. S.E. McNeil, I. Rosenkrands, E.M. Agger, P. Andersen, Y. Perrie, Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system, J. Pharm. Sci.
35. C. Oussoren, and G. Storm Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol) Pharm. Res. 14 1997 1479 1484
36. C. Foged, B. Brodin, S. Frokjaer, and A. Sundblad Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model Int. J. Pharm. 298 2005 315 322
37. T. van den Hoorn, P. Paul, M.L. Jongsma, and J. Neefjes Routes to manipulate MHC class II antigen presentation Curr. Opin. Immunol. 23 2011 88 95
38. H.F. Kuipers, P.J. Biesta, T.A. Groothuis, J.J. Neefjes, A.M. Mommaas, and P.J. van den Elsen Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol- containing microdomains Hum. Immunol. 66 2005 653 665
39. K.S. Korsholm, E.M. Agger, C. Foged, D. Christensen, J. Dietrich, C.S. Andersen, C. Geisler, and P. Andersen The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes Immunology 121 2007 216 226
40. M. Cremel, H. Hamzeh-Cognasse, C. Genin, and O. Delezay Female genital tract immunization: evaluation of candidate immunoadjuvants on epithelial cell secretion of CCL20 and dendritic/Langerhans cell maturation Vaccine 24 2006 5744 5754
41. D. Mohanan, B. Slütter, M. Henriksen-Lacey, W. Jiskoot, J.A. Bouwstra, Y. Perrie, T.M. Kundig, B. Gander, and P. Johansen Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems J. Control. Release 147 2010 342 349